USD10
LRMR Shares
About Larimar TherapeuticsLarimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.
USD10
LRMR Shares
About Larimar TherapeuticsLarimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.
Stats
TRADING WINDOW
Closed
OPENS AT
Apr 9 at 1:30 PM GMT+0
MARKET CAP
$422.93M
OPEN PRICE
Not enough data
LOW (1Y)
$1.61
HIGH (1Y)
$5.37
LOW (24H)
Not enough data
HIGH (24H)
Not enough data
VOLUME (24H)
Not enough data
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $5.06 | |
1 Week | $4.46 | |
1 Month | $4.89 | |
1 Year | $1.78 |
Past performance is not a reliable indicator of future results.
Discover more
Popular stocks
Explore other stocks
Popular cryptocurrencies
Most popular conversions
Popular derivatives
Learn how to buy popular cryptocurrencies
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
